IBDEI0DC ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6030,2)
 ;;=^60611
 ;;^UTILITY(U,$J,358.3,6031,0)
 ;;=278.02^^31^404^17
 ;;^UTILITY(U,$J,358.3,6031,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6031,1,4,0)
 ;;=4^278.02
 ;;^UTILITY(U,$J,358.3,6031,1,5,0)
 ;;=5^Overweight
 ;;^UTILITY(U,$J,358.3,6031,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,6032,0)
 ;;=285.9^^31^404^3
 ;;^UTILITY(U,$J,358.3,6032,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6032,1,4,0)
 ;;=4^285.9
 ;;^UTILITY(U,$J,358.3,6032,1,5,0)
 ;;=5^Anemia NOS
 ;;^UTILITY(U,$J,358.3,6032,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,6033,0)
 ;;=790.29^^31^404^1
 ;;^UTILITY(U,$J,358.3,6033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6033,1,4,0)
 ;;=4^790.29
 ;;^UTILITY(U,$J,358.3,6033,1,5,0)
 ;;=5^Abnormal Glucose NOS
 ;;^UTILITY(U,$J,358.3,6033,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,6034,0)
 ;;=252.00^^31^404^9
 ;;^UTILITY(U,$J,358.3,6034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6034,1,4,0)
 ;;=4^252.00
 ;;^UTILITY(U,$J,358.3,6034,1,5,0)
 ;;=5^Hyperparathyroid NOS
 ;;^UTILITY(U,$J,358.3,6034,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,6035,0)
 ;;=252.01^^31^404^18
 ;;^UTILITY(U,$J,358.3,6035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6035,1,4,0)
 ;;=4^252.01
 ;;^UTILITY(U,$J,358.3,6035,1,5,0)
 ;;=5^Primary Hyperparathyroid
 ;;^UTILITY(U,$J,358.3,6035,2)
 ;;=^331439
 ;;^UTILITY(U,$J,358.3,6036,0)
 ;;=252.02^^31^404^19
 ;;^UTILITY(U,$J,358.3,6036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6036,1,4,0)
 ;;=4^252.02
 ;;^UTILITY(U,$J,358.3,6036,1,5,0)
 ;;=5^Sec Hyperparathyroid NonRenal
 ;;^UTILITY(U,$J,358.3,6036,2)
 ;;=^331440
 ;;^UTILITY(U,$J,358.3,6037,0)
 ;;=252.08^^31^404^10
 ;;^UTILITY(U,$J,358.3,6037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6037,1,4,0)
 ;;=4^252.08
 ;;^UTILITY(U,$J,358.3,6037,1,5,0)
 ;;=5^Hyperparathyroidism Oth
 ;;^UTILITY(U,$J,358.3,6037,2)
 ;;=^331441
 ;;^UTILITY(U,$J,358.3,6038,0)
 ;;=793.2^^31^405^3
 ;;^UTILITY(U,$J,358.3,6038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6038,1,4,0)
 ;;=4^793.2
 ;;^UTILITY(U,$J,358.3,6038,1,5,0)
 ;;=5^Abnormal Chest x-ray, other
 ;;^UTILITY(U,$J,358.3,6038,2)
 ;;=^273419
 ;;^UTILITY(U,$J,358.3,6039,0)
 ;;=493.92^^31^405^10
 ;;^UTILITY(U,$J,358.3,6039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6039,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,6039,1,5,0)
 ;;=5^Asthma, Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,6039,2)
 ;;=^322001
 ;;^UTILITY(U,$J,358.3,6040,0)
 ;;=493.20^^31^405^17
 ;;^UTILITY(U,$J,358.3,6040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6040,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,6040,1,5,0)
 ;;=5^COPD with Asthma
 ;;^UTILITY(U,$J,358.3,6040,2)
 ;;=COPD with Asthma^269964
 ;;^UTILITY(U,$J,358.3,6041,0)
 ;;=493.91^^31^405^11
 ;;^UTILITY(U,$J,358.3,6041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6041,1,4,0)
 ;;=4^493.91
 ;;^UTILITY(U,$J,358.3,6041,1,5,0)
 ;;=5^Asthma, with Status Asthmat
 ;;^UTILITY(U,$J,358.3,6041,2)
 ;;=^269967
 ;;^UTILITY(U,$J,358.3,6042,0)
 ;;=491.21^^31^405^16
 ;;^UTILITY(U,$J,358.3,6042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6042,1,4,0)
 ;;=4^491.21
 ;;^UTILITY(U,$J,358.3,6042,1,5,0)
 ;;=5^COPD Exacerbation
 ;;^UTILITY(U,$J,358.3,6042,2)
 ;;=COPD Exacerbation^269954
 ;;^UTILITY(U,$J,358.3,6043,0)
 ;;=494.0^^31^405^14
 ;;^UTILITY(U,$J,358.3,6043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6043,1,4,0)
 ;;=4^494.0
 ;;^UTILITY(U,$J,358.3,6043,1,5,0)
 ;;=5^Bronchiectasis, chronic
 ;;^UTILITY(U,$J,358.3,6043,2)
 ;;=^321990
 ;;^UTILITY(U,$J,358.3,6044,0)
 ;;=494.1^^31^405^13
 ;;^UTILITY(U,$J,358.3,6044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6044,1,4,0)
 ;;=4^494.1
 ;;^UTILITY(U,$J,358.3,6044,1,5,0)
 ;;=5^Bronchiectasis with exacerb
 ;;
 ;;$END ROU IBDEI0DC
